Literature DB >> 4643487

[Studies on the effect of uremia on phenylbutazone and aminophenazone metabolism in man].

H W Leber, A Harders, G Schütterle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4643487     DOI： 10.1007/bf01486853

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  13 in total

1.  DISAPPEARANCE RATE OF TOLBUTAMIDE IN NORMAL SUBJECTS AND IN DIABETES MELLITUS, LIVER CIRRHOSIS, AND RENAL DISEASE.

Authors:  H UEDA; T SAKURAI; M OTA; A NAKAJIMA; K KAMII; H MAEZAWA
Journal:  Diabetes       Date:  1963 Sep-Oct       Impact factor: 9.461

2.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors:  A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

3.  Gastrointestinal lesions occurring in uremia.

Authors:  E E MASON
Journal:  Ann Intern Med       Date:  1952-07       Impact factor: 25.391

4.  The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1950-06       Impact factor: 4.030

5.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

6.  [Effect of uremia on the drug-catalolizing enzymes in rat liver microsomes].

Authors:  H W Leber; P Streitzig; M Kayser; G Schütterle
Journal:  Klin Wochenschr       Date:  1971-08-15

7.  Effect of adrenalectomy and cortisone administration on components of the liver microsomal mixed function oxygenase system of male rats which catalyzes ethylmorphine metabolism.

Authors:  J A Castro; F E Greene; P Gigon; H Sasame; J R Gillette
Journal:  Biochem Pharmacol       Date:  1970-08       Impact factor: 5.858

8.  Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.

Authors:  R Kato; J R Gillette
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

9.  Oxidative drug metabolism in liver microsomes from uremic rats.

Authors:  H W Leber; G Schütterle
Journal:  Kidney Int       Date:  1972-09       Impact factor: 10.612

10.  Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.

Authors:  D S Davies; S S Thorgeirsson
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691
View more
  5 in total

1.  Assessment of liver ability to biotransformation of antipyrine in uraemic patients on regular peritoneal dialysis treatment.

Authors:  A Grzegorzewska; Z Lowicki; E Chmara; A Mrozikiewicz; K Baczyk
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 2.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 3.  Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone).

Authors:  M Volz; H M Kellner
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

4.  Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.

Authors:  M A Kassem; K E Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

Review 5.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.